Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen reports higher third-quarter profit
Marketwatch
Wednesday, October 21, 2009 - 5:13pm
tags:
Amgen, earnings
Earnings Preview: Celgene
Seeking Alpha
Wednesday, October 21, 2009 - 2:35pm
tags:
earnings, Celgene
Earnings Preview: Amgen
Seeking Alpha
Wednesday, October 21, 2009 - 2:35pm
tags:
earnings, Amgen
NICE stiff-arms Glaxo's Tyverb--again
Fierce Pharma
Wednesday, October 21, 2009 - 2:34pm
tags:
UK, GSK, Tyverb, breast cancer
King Pharmaceuticals gets FDA request on stress imaging agent, potentially delaying approval
Yahoo/AP
Wednesday, October 21, 2009 - 2:32pm
tags:
King, imaging, FDA, Corvue
Pharma at the tipping point II: Emerging markets
Eye for Pharma
Wednesday, October 21, 2009 - 10:59am
tags:
pharma industry
Merck Cancer Vaccine May Not Win Routine Use in Boys
Bloomberg
Wednesday, October 21, 2009 - 10:58am
tags:
Merck, Gardasil, vaccines, HPV
Amylin Loss Narrows
Yahoo/Zacks.com
Wednesday, October 21, 2009 - 10:56am
tags:
Amylin, earnings
Never Mind The Delay, Amgen Puts D'mab on its Website
InVivo
Wednesday, October 21, 2009 - 10:33am
tags:
Amgen, denosumab, Prolia
Amgen Fired Manager Over Adverse Events?
Pharmalot
Wednesday, October 21, 2009 - 10:14am
tags:
Amgen
Genzyme Posts Lower Profit, Cuts View
TheStreet.com
Wednesday, October 21, 2009 - 10:12am
tags:
Genzyme, earnings
Simcere to Develop OSI Pharmaceutical Cancer Drug in China
Seeking Alpha
Wednesday, October 21, 2009 - 10:12am
tags:
China, Simcere, OSI Pharmaceuticals, cancer
Europe Rejects Antigenics Cancer Vaccine
TheStreet.com
Wednesday, October 21, 2009 - 10:11am
tags:
Europe, Antigenics, kidney cancer, vaccines, Oncophage
Will Novartis Be Found Guilty Of Denying Zometa Risks?
Pharmalot
Wednesday, October 21, 2009 - 10:10am
tags:
Zometa, Novartis
Big Pharma Immune to Obama Overhaul
TheStreet.com
Wednesday, October 21, 2009 - 10:09am
tags:
Obama, healthcare reform, Pfizer, Merck, Bristol-Myers Squibb, GSK
Take Your Position: Amgen
CNBC
Wednesday, October 21, 2009 - 9:23am
tags:
Amgen, earnings
Sanofi Expands in Diabetes With Rights to Novel Drug
Bloomberg
Wednesday, October 21, 2009 - 9:22am
tags:
diabetes, Sanofi, Lantus, insulin, M&A, Wellstat
Lilly swings to profit on solid sales, year-ago charges
Marketwatch
Wednesday, October 21, 2009 - 9:22am
tags:
Eli Lilly, earnings
Elan pins hopes on multiple sclerosis drug
FT.com
Wednesday, October 21, 2009 - 9:21am
tags:
Elan, MS, multiple sclerosis, Tysabri, JNJ
Pfizer Fills Its Pipe
CNBC
Tuesday, October 20, 2009 - 5:51pm
tags:
Pfizer, Wyeth, M&A, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.